Swiss drugmaker Novartis has announced to discontinue Hydroxychloroquine (HCQ) clinical trial over acute enrollment challenges that have made the completion of the trial infeasible,...
Overbilling for Covid-19 treatment by private hospitals has emerged as another roadblock for the Delhi government after it recently received flak from the Supreme...